T wave alternans is a predictor of death in patients with congestive heart failure

Simona Sarzi Braga1, Raffaella Vaninetti, Antonio Laporta

  • 1IRCCS Fondazione Salvatore Maugeri, Divisione di Cardiologia, Istituto Scientifico di Tradate, Via Roncaccio 16 I-21049, Tradate (VA), Italy. ssarzibraga@fsm.it

Insights

T wave alternans can predict cardiac death in heart failure patients. Combining it with oxygen consumption measurements offers marginal additional prognostic value for cardiac events.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Heart Failure Research

Background:

  • Limited data exist on the prognostic significance of T wave alternans in congestive heart failure.
  • Assessing cardiac death predictors is crucial for managing decompensated heart failure patients.

Purpose of the Study:

  • To evaluate T wave alternans' ability to predict cardiac death in decompensated heart failure.
  • To determine if T wave alternans improves risk prediction when combined with other markers like oxygen consumption.

Main Methods:

  • Prospective study of 46 decompensated heart failure patients.
  • T wave alternans assessment, exercise testing (oxygen consumption), and hemodynamic measurements (wedge pressure).
  • Follow-up for cardiac death prediction using survival analysis and ROC curves.

Main Results:

  • T wave alternans was positive in all cardiac death events (100%) versus 41% without events (P=0.02).
  • Oxygen consumption, NN interval variability, and wedge pressure also predicted cardiac death.
  • Combined T wave alternans and oxygen consumption showed a trend towards better prediction (AUC 0.79 vs 0.73).

Conclusions:

  • T wave alternans is a potential predictor of cardiac death in heart failure.
  • It offers marginal additional prognostic power when combined with oxygen consumption measurements.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Electrocardiogram01:29

Electrocardiogram

An electrocardiogram (ECG or EKG) is a critical diagnostic tool that records the electrical signals produced by the heart during each heartbeat. This recording is achieved through electrodes placed strategically on the arms, legs, and chest. The electrocardiograph amplifies these signals and produces 12 distinct tracings, offering a comprehensive understanding of the heart's electrical activity.
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and the T...
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...